A new publication involving terlipressin was listed on October 19, 2026. The paper, titled "Vasopressors Combination Therapy (Norepinephrine Plus Vasopressin Receptor Agonists) Improve Septic Shock Outcome: A Systematic Review and Meta-Analysis," appeared in the Journal of Intensive Care Medicine.
The publication is identified as a systematic review and meta-analysis. It addresses combination vasopressor therapy using norepinephrine together with vasopressin receptor agonists in the context of septic shock.
Terlipressin is referenced within this body of literature as a vasopressin receptor agonist category compound. No specific findings, outcome data, or conclusions from the analysis are detailed here beyond the publication's title and journal listing.
This brief reports only the existence and bibliographic details of the publication. It does not summarize or interpret any results, efficacy claims, or safety conclusions contained within the article itself.
Readers interested in the broader context of terlipressin, including its approved regulatory status and general background, can consult the compound overview for additional information.